ovarian cancer

17 all articles · 20 / page

Ask MedXY AI

Latest news

Tag

All articles

news

PRO-PLATINUM Trial: Probiotic Modulation of the Microbiome to Enhance Outcomes in Ovarian Cancer Chemotherapy

By MedXY|Jun 29, 2026

The PRO-PLATINUM trial evaluates a novel 5-strain probiotic’s effect on gut and vaginal microbiome composition and clinical outcomes in ovarian cancer patients undergoing platinum chemotherapy, assessing safety, feasibility, and translation

news

ovarian cancer

Latest news

PRO-PLATINUM Trial: Probiotic Modulation of the Microbiome to Enhance Outcomes in Ovarian Cancer Chemotherapy

Long-Term Outcomes and Durability of Exceptional Responses to PARP Inhibitors in Recurrent Platinum-Sensitive Ovarian Cancer

Family History Misses Actionable Germline Variants in Many Ovarian Cancer Patients Over 70

Estrogen Therapy Linked to Improved Survival in Certain Ovarian Cancer Patients Under 60

Real-world Evidence: Managing Platelet Counts in Ovarian Cancer Patients on First-Line Maintenance Niraparib

Lymph Node Isolated Tumor Cells in Ovarian Cancer: Clinically Significant or Pathological Incidentaloma?

Mobile App-Led Self-Acupressure: A Scalable Solution for Ovarian Cancer-Related Fatigue

A Proactive Approach to Ovarian Cancer: The New ESGO Consensus on Opportunistic Salpingectomy

Opportunistic Bilateral Salpingectomy Reduces Serous Ovarian Cancer Risk by Nearly 80 Percent

Beyond the Incessant Ovulation Hypothesis: How Menopausal Status and Birth Cohort Reshape Ovarian Cancer Risk

Biomarker-Driven Precision in Low-Grade Serous Ovarian Cancer: pERK and MAPK Mutations as Predictors of Trametinib Efficacy

Atezolizumab Plus Bevacizumab and Chemotherapy in Recurrent Ovarian Cancer: Two Phase III Trials Fall Short of Practice‑Changing Benefit

Defining Clinical Effectiveness of Risk-Reducing Early Salpingectomy in High-Risk BRCA Carriers: Insights from the PROTECTOR Cohort

Metformin in Gynecologic Cancers: A Comprehensive Review of Evidence in Cervical, Ovarian, and Endometrial Cancer

Early Signs of Ovarian Cancer: Understanding the Three Common Areas of Itching and Common Misdiagnoses Among Women

Relacorilant Plus Nab-Paclitaxel: A New Standard for Platinum-Resistant Ovarian Cancer?

Ovarian Cancer Risk Peaks Shortly After New IBS Diagnosis: Clinical Implications and Evidence Review